RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone
Status:
Withdrawn
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine if the combination of goal directed iron
supplementation and hepcidin mitigation can safely eliminate both the serum and bone marrow
iron debt of anemic, critically ill trauma patients with functional iron deficiency.
Phase:
Phase 2
Details
Lead Sponsor:
Denver Health and Hospital Authority
Treatments:
Ferric Compounds Ferric Oxide, Saccharated Iron Oxandrolone